Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Tumber

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Plos One|July 7, 2015
Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine BrainMun Chiang Chan, Onur Atasoylu, Emma Hodson, et al.
Nature Chemistry|April 15, 2026
KDM3A catalyses the oxidation of acetyl-lysine to hydroxyacetyl-lysine on histone H3K9Roman Belle, John-Paul Bukowski, Rachel Schiller, et al.
Angewandte Chemie (International Ed. in English)|May 14, 2014
A series of potent CREBBP bromodomain ligands reveals an induced-fit pocket stabilized by a cation-π interactionTimothy P C Rooney, Panagis Filippakopoulos, Oleg Fedorov, et al.
Journal of the American Chemical Society|June 20, 2014
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomainsDuncan A Hay, Oleg Fedorov, Sarah Martin, et al.
Science Advances|June 21, 2023
Accelerating drug target inhibitor discovery with a deep generative foundation modelVijil Chenthamarakshan, Samuel C Hoffman, C David Owen, et al.
ACS Chemical Biology|May 21, 2013
Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylasesRasheduzzaman Chowdhury, José Ignacio Candela-Lena, Mun Chiang Chan, et al.
Angewandte Chemie (International Ed. in English)|October 5, 2017
Discovery of a Highly Selective Cell-Active Inhibitor of the Histone Lysine Demethylases KDM2/7Philip A Gerken, Jamie R Wolstenhulme, Anthony Tumber, et al.
Journal of Medicinal Chemistry|November 29, 2021
First-in-Class Inhibitors of the Ribosomal Oxygenase MINA53Radosław P Nowak, Anthony Tumber, Eline Hendrix, et al.
Nature Chemical Biology|May 24, 2016
Structural analysis of human KDM5B guides histone demethylase inhibitor developmentCatrine Johansson, Srikannathasan Velupillai, Anthony Tumber, et al.
Chemical Science|February 14, 2018
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trialsTzu-Lan Yeh, Thomas M Leissing, Martine I Abboud, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Plos One|July 7, 2015
Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine BrainMun Chiang Chan, Onur Atasoylu, Emma Hodson, et al.
Nature Chemistry|April 15, 2026
KDM3A catalyses the oxidation of acetyl-lysine to hydroxyacetyl-lysine on histone H3K9Roman Belle, John-Paul Bukowski, Rachel Schiller, et al.
Angewandte Chemie (International Ed. in English)|May 14, 2014
A series of potent CREBBP bromodomain ligands reveals an induced-fit pocket stabilized by a cation-π interactionTimothy P C Rooney, Panagis Filippakopoulos, Oleg Fedorov, et al.
Journal of the American Chemical Society|June 20, 2014
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomainsDuncan A Hay, Oleg Fedorov, Sarah Martin, et al.
Science Advances|June 21, 2023
Accelerating drug target inhibitor discovery with a deep generative foundation modelVijil Chenthamarakshan, Samuel C Hoffman, C David Owen, et al.
ACS Chemical Biology|May 21, 2013
Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylasesRasheduzzaman Chowdhury, José Ignacio Candela-Lena, Mun Chiang Chan, et al.
Angewandte Chemie (International Ed. in English)|October 5, 2017
Discovery of a Highly Selective Cell-Active Inhibitor of the Histone Lysine Demethylases KDM2/7Philip A Gerken, Jamie R Wolstenhulme, Anthony Tumber, et al.
Journal of Medicinal Chemistry|November 29, 2021
First-in-Class Inhibitors of the Ribosomal Oxygenase MINA53Radosław P Nowak, Anthony Tumber, Eline Hendrix, et al.
Nature Chemical Biology|May 24, 2016
Structural analysis of human KDM5B guides histone demethylase inhibitor developmentCatrine Johansson, Srikannathasan Velupillai, Anthony Tumber, et al.
Chemical Science|February 14, 2018
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trialsTzu-Lan Yeh, Thomas M Leissing, Martine I Abboud, et al.
Pageof 11